本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akero Therapeutics

55.62
+2.063.85%
盘后54.65-0.9699-1.74%19:12 EDT
成交量:222.46万
成交额:1.22亿
市值:44.34亿
市盈率:-14.86
高:55.83
开:52.19
低:52.19
收:53.56
数据加载中...
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/18

重要事件披露

Form 8-K - Current report
2023/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/13

重要事件披露

Form 8-K - Current report
2023/10/10

重要事件披露

Form 8-K - Current report
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/26

重要事件披露

Form 8-K - Current report
2023/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities